BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 18792765)

  • 1. TGF-beta and regulatory T cell in immunity and autoimmunity.
    Wan YY; Flavell RA
    J Clin Immunol; 2008 Nov; 28(6):647-59. PubMed ID: 18792765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation.
    Wan YY; Flavell RA
    Immunol Rev; 2007 Dec; 220():199-213. PubMed ID: 17979848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
    Zhang L; Yi H; Xia XP; Zhao Y
    Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical Role of TGF-β and IL-2 Receptor Signaling in Foxp3 Induction by an Inhibitor of DNA Methylation.
    Freudenberg K; Lindner N; Dohnke S; Garbe AI; Schallenberg S; Kretschmer K
    Front Immunol; 2018; 9():125. PubMed ID: 29456534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Garp as a therapeutic target for modulation of T regulatory cell function.
    Shevach EM
    Expert Opin Ther Targets; 2017 Feb; 21(2):191-200. PubMed ID: 28001437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3⁺ regulatory T cells through preferential expansion and usage of interleukin-2.
    Chambers ES; Suwannasaen D; Mann EH; Urry Z; Richards DF; Lertmemongkolchai G; Hawrylowicz CM
    Immunology; 2014 Sep; 143(1):52-60. PubMed ID: 24673126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β Control of Adaptive Immune Tolerance: A Break From Treg Cells.
    Liu M; Li S; Li MO
    Bioessays; 2018 Nov; 40(11):e1800063. PubMed ID: 30159904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
    Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
    J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4
    Polanczyk MJ; Walker E; Haley D; Guerrouahen BS; Akporiaye ET
    J Transl Med; 2019 Jul; 17(1):219. PubMed ID: 31288845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery.
    Ito T; Hanabuchi S; Wang YH; Park WR; Arima K; Bover L; Qin FX; Gilliet M; Liu YJ
    Immunity; 2008 Jun; 28(6):870-80. PubMed ID: 18513999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
    You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta and 'adaptive' Foxp3(+) regulatory T cells.
    Chen W; Konkel JE
    J Mol Cell Biol; 2010 Feb; 2(1):30-6. PubMed ID: 19648226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerogenic dendritic cells induced the enrichment of CD4
    Jia L; Lu J; Zhou Y; Tao Y; Xu H; Zheng W; Zhao J; Liang G; Xu L
    Clin Immunol; 2018 Dec; 197():118-129. PubMed ID: 30248398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of foxp3+ T regulatory cell-mediated suppression.
    Shevach EM
    Immunity; 2009 May; 30(5):636-45. PubMed ID: 19464986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human FOXP3
    Wing JB; Tanaka A; Sakaguchi S
    Immunity; 2019 Feb; 50(2):302-316. PubMed ID: 30784578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β regulation of encephalitogenic and regulatory T cells in multiple sclerosis.
    Lee PW; Severin ME; Lovett-Racke AE
    Eur J Immunol; 2017 Mar; 47(3):446-453. PubMed ID: 28102541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T-cell immunity and its relevance to atherosclerosis.
    Taleb S; Tedgui A; Mallat Z
    J Intern Med; 2008 May; 263(5):489-99. PubMed ID: 18410592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming Growth Factor-β Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses.
    Konkel JE; Zhang D; Zanvit P; Chia C; Zangarle-Murray T; Jin W; Wang S; Chen W
    Immunity; 2017 Apr; 46(4):660-674. PubMed ID: 28423340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.
    Dardalhon V; Awasthi A; Kwon H; Galileos G; Gao W; Sobel RA; Mitsdoerffer M; Strom TB; Elyaman W; Ho IC; Khoury S; Oukka M; Kuchroo VK
    Nat Immunol; 2008 Dec; 9(12):1347-55. PubMed ID: 18997793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2 and IL-15 dependent thymic development of Foxp3-expressing regulatory T lymphocytes.
    Apert C; Romagnoli P; van Meerwijk JPM
    Protein Cell; 2018 Apr; 9(4):322-332. PubMed ID: 28540653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.